United States · FDA National Drug Code directory
Propafenone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1525_e7389f3e-074b-44ca-b767-5520390265e5
- Product NDC
- 70771-1525
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Propafenone Hydrochloride
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220202
- Source listing expiry
- 20261231
Source-listed ingredients
- PROPAFENONE HYDROCHLORIDE — 225 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-5) · 70771-1525-5
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-6) · 70771-1525-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →